Ryota Ebata

A genome-wide association study identifies three new risk loci for Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Burns et al. · Nature Genetics · 2012 · 337 citations

Life Sciences, Genetics, Molecular Genetics +13

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

Yoshihiro Onouchi, Yoichi Suzuki, Hiroyuki Suzuki et al. · The Pharmacogenomics Journal · 2011 · 125 citations

Medicine, Cardiology, Genetics +16

Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999–2010 in Japan

Ryuji Fukazawa, Tohru Kobayashi, Masashi Mikami et al. · Circulation Journal · 2017 · 76 citations · Full text

Medicine, Cardiology, Internal Medicine +10

Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease

Jun Abe, Ryota Ebata, Toshiaki Jibiki et al. · Journal of Allergy and Clinical Immunology · 2008 · 57 citations

Life Sciences, Hematology, Immunology +8